Temozolomide,Thiotepa and Carboplatin With Autologous Stem Cell Rescue Followed by 13-cis-retinoic Acid in Patients With Recurrent/Refractory Malignant Brain Tumors

This study is currently recruiting participants.

Study NCT00528437 Information provided by New York University School of Medicine

First Received: September 10, 2007 Last Updated: January 5, 2012 History of Changes

No Study Results Posted on ClinicalTrials.gov for this Study

Study Status:	This study is currently recruiting participants.
Estimated Study Completion Date:	July 2014
Estimated Primary Completion Date:	September 2012 (Final data collection date for primary outcome measure)